A parsimonious model to validate cost-effectiveness analyses on preventive health care
Abstract Background The effect of preventive health care on health expenditures is ambiguous. On the one hand, prevention reduces the costs of future morbidity. On the other hand, prevention leads to costs of life extension. The purpose of this paper is to develop a parsimonious model that determine...
Saved in:
Main Author: | Afschin Gandjour (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modelling the cost-effectiveness and budget impact of pay-for-performance programs in health care
by: Afschin Gandjour
Published: (2024) -
Long COVID: Costs for the German economy and health care and pension system
by: Afschin Gandjour
Published: (2023) -
Inclusion of phase III clinical trial costs in health economic evaluations
by: Afschin Gandjour
Published: (2024) -
Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer's perspective
by: Afschin Gandjour
Published: (2022) -
Was EU's COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations
by: Afschin Gandjour
Published: (2022)